Monitor the company's ability to recruit LCP-certified physicians and expand clinics as planned, while watching for potential governance issues from the dual-class structure and concentrated ownership. The IPO valuation appears reasonable based on current financials, but execution risk remains high.
Executive Summary
I Bella Perfect Inc., a British Virgin Islands holding company, operates aesthetic medical clinics in Malaysia through its subsidiaries. The company is conducting an IPO of 3.75 million Class A shares priced at $4.00-$6.00, with proceeds to fund clinic expansion, marketing, and equipment purchases. The company has strong revenue growth but faces risks from concentrated ownership, dual-class shares, and material weaknesses in internal controls.
Key Financial Metrics
Key Facts
- Company operates three aesthetic clinics in Malaysia (Kuala Lumpur, Selangor, Johor) providing non-invasive and minimally invasive procedures
- Revenue grew 22.7% YoY to RM18.6 million ($4.2M) for FY2025, with 96.9% from aesthetic services and 3.1% from skincare products
- Dual-class share structure gives Class B shares 20x voting power, with founders controlling 86.8% of voting power post-IPO
- Material weaknesses identified in internal controls over financial reporting related to IFRS/SEC knowledge and risk assessment processes
- Net proceeds from IPO ($12.6M-$14.7M) to be used for new clinics (30%), marketing (30%), equipment (20%), and working capital (20%)
Financial Impact
Revenue of $4.2M in FY2025 with 12.5% net income growth; IPO to raise $12.6M-$14.7M net proceeds
Risk Factors
- Concentrated ownership and dual-class structure limit shareholder influence
- Material weaknesses in internal controls could impact financial reporting
- Heavy reliance on limited number of LCP-certified physicians creates operational risk
- Expansion plans dependent on successful recruitment and execution
Investment Themes
Documents Analyzed
This report is based on 9 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| F-1/A Filing (Primary) | 0001213900-26-025384 |
| Document: ea024717709_ex5-1.htm | 0001213900-26-025384 |
| Document: ea024717709_ex99-10.htm | 0001213900-26-025384 |
| Document: ea024717709_ex10-6.htm | 0001213900-26-025384 |
| Document: ea024717709_ex-fee.htm | 0001213900-26-025384 |
| Document: ea024717709ex23-1.htm | 0001213900-26-025384 |
| Document: 0001213900-26-025384-index-headers.html | 0001213900-26-025384 |
| Document: 0001213900-26-025384-index.html | 0001213900-26-025384 |
| Document: 0001213900-26-025384.txt | 0001213900-26-025384 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Apr 29, 2026 25w ago | F-1/A | — | awaiting T+20 | — | — |
Mar 25, 2026 30w ago | F-1/A | — | awaiting T+20 | — | — |
Mar 9, 2026 32w ago | F-1/A | — | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers